May 8, 2024
Tommy Tuberville- Amount
- $1,001 to $15,000
- Filed
- Aug 5, 2026
Congress ticker disclosure profile
As of August 5 at 6:37 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference XBI. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
5
Disclosed ranges
$73K
Most active member desks
8 buys vs 3 sells
Latest trade May 8, 2024
May 8, 2024
Tommy TubervilleJun 30, 2023
David P. JoyceSep 30, 2019
James M. InhofeDec 31, 2018
James M. InhofeMar 9, 2018
Jack ReedJun 19, 2017
Jack ReedMar 6, 2017
Jack ReedMar 6, 2017
Jack ReedFeb 23, 2017
David P. JoyceFeb 17, 2017
David P. JoyceOct 2, 2015
Pete Sessions| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| May 8, 2024 | Tommy Tuberville | Buy | $1,001 to $15,000 | Aug 5, 2026 | Open card |
| Jun 30, 2023 | David P. Joyce | Sell | $15,001 to $50,000 | Aug 6, 2024 | Open card |
| Sep 30, 2019 | James M. Inhofe | Sell | Receipt pending ingestion | Oct 18, 2019 | Receipt pending ingestion |
| Dec 31, 2018 | James M. Inhofe | Buy | Receipt pending ingestion | Jan 9, 2019 | Receipt pending ingestion |
| Mar 9, 2018 | Jack Reed | Sell | $1,001 to $15,000 | Mar 12, 2018 | Open card |
| Jun 19, 2017 | Jack Reed | Buy | $1,001 to $15,000 | Jun 20, 2017 | Open card |
| Mar 6, 2017 | Jack Reed | Buy | $1,001 to $15,000 | Mar 7, 2017 | Open card |
| Mar 6, 2017 | Jack Reed | Buy | $1,001 to $15,000 | Mar 7, 2017 | Open card |
| Feb 23, 2017 | David P. Joyce | Buy | Receipt pending ingestion | May 8, 2019 | Open card |
| Feb 17, 2017 | David P. Joyce | Buy | Receipt pending ingestion | Jul 26, 2017 | Open card |
| Oct 2, 2015 | Pete Sessions | Buy | Receipt pending ingestion | May 18, 2016 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 6 of 11 filed rows include disclosed amount ranges (55%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.